Merck's Keytruda Combined with Chemoradiotherapy Gets FDA Approval to Treat Cervical Cancer
January 12 2024 - 5:13PM
Dow Jones News
By Denny Jacob
Merck received approval from the Food and Drug Administration
for cancer drug Keytruda in combination with chemoradiotherapy as a
treatment for patients with FIGO 2014 Stage III-IVA cervical
cancer.
The healthcare company said the approval marks the third
indication for keytruda in cervical cancer and the 39th indication
for keytruda in the United States.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
January 12, 2024 17:58 ET (22:58 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024
